204 related articles for article (PubMed ID: 34174937)
1. Recommendations for designing and analysing multi-arm non-inferiority trials: a review of methodology and current practice.
Emmerson J; Todd S; Brown JM
Trials; 2021 Jun; 22(1):417. PubMed ID: 34174937
[TBL] [Abstract][Full Text] [Related]
2. Designs for adding a treatment arm to an ongoing clinical trial.
Bennett M; Mander AP
Trials; 2020 Mar; 21(1):251. PubMed ID: 32143729
[TBL] [Abstract][Full Text] [Related]
3. Some essential considerations in the design and conduct of non-inferiority trials.
Fleming TR; Odem-Davis K; Rothmann MD; Li Shen Y
Clin Trials; 2011 Aug; 8(4):432-9. PubMed ID: 21835862
[TBL] [Abstract][Full Text] [Related]
4. Testing non-inferiority of a new treatment in three-arm clinical trials with binary endpoints.
Tang NS; Yu B; Tang ML
BMC Med Res Methodol; 2014 Dec; 14():134. PubMed ID: 25524326
[TBL] [Abstract][Full Text] [Related]
5. Controlling the family-wise error rate in multi-arm, multi-stage trials.
Crouch LA; Dodd LE; Proschan MA
Clin Trials; 2017 Jun; 14(3):237-245. PubMed ID: 28545335
[TBL] [Abstract][Full Text] [Related]
6. Recommendations on multiple testing adjustment in multi-arm trials with a shared control group.
Howard DR; Brown JM; Todd S; Gregory WM
Stat Methods Med Res; 2018 May; 27(5):1513-1530. PubMed ID: 27647808
[TBL] [Abstract][Full Text] [Related]
7. Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation.
Quartagno M; Walker AS; Babiker AG; Turner RM; Parmar MKB; Copas A; White IR
Trials; 2020 Feb; 21(1):145. PubMed ID: 32029000
[TBL] [Abstract][Full Text] [Related]
8. Statistical methods for the analysis of two-arm non-inferiority trials with binary outcomes.
Wellek S
Biom J; 2005 Feb; 47(1):48-61; discussion 99-107. PubMed ID: 16395996
[TBL] [Abstract][Full Text] [Related]
9. Type I error rates of multi-arm multi-stage clinical trials: strong control and impact of intermediate outcomes.
Bratton DJ; Parmar MK; Phillips PP; Choodari-Oskooei B
Trials; 2016 Jul; 17(1):309. PubMed ID: 27369182
[TBL] [Abstract][Full Text] [Related]
10. Adding a treatment arm to an ongoing clinical trial: a review of methodology and practice.
Cohen DR; Todd S; Gregory WM; Brown JM
Trials; 2015 Apr; 16():179. PubMed ID: 25897686
[TBL] [Abstract][Full Text] [Related]
11. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
Allen D; Gillen E; Rixson L
JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
[TBL] [Abstract][Full Text] [Related]
12. Controlling type I error rates in multi-arm clinical trials: A case for the false discovery rate.
Wason JMS; Robertson DS
Pharm Stat; 2021 Jan; 20(1):109-116. PubMed ID: 32790026
[TBL] [Abstract][Full Text] [Related]
13. Some recommendations for multi-arm multi-stage trials.
Wason J; Magirr D; Law M; Jaki T
Stat Methods Med Res; 2016 Apr; 25(2):716-27. PubMed ID: 23242385
[TBL] [Abstract][Full Text] [Related]
14. Challenges in the design and analysis of non-inferiority trials: a case study.
Durkalski V; Silbergleit R; Lowenstein D
Clin Trials; 2011 Oct; 8(5):601-8. PubMed ID: 21921062
[TBL] [Abstract][Full Text] [Related]
15. Non-adjustment for multiple testing in multi-arm trials of distinct treatments: Rationale and justification.
Parker RA; Weir CJ
Clin Trials; 2020 Oct; 17(5):562-566. PubMed ID: 32666813
[TBL] [Abstract][Full Text] [Related]
16. Correcting for multiple-testing in multi-arm trials: is it necessary and is it done?
Wason JM; Stecher L; Mander AP
Trials; 2014 Sep; 15():364. PubMed ID: 25230772
[TBL] [Abstract][Full Text] [Related]
17. Multiple comparisons in non-inferiority trials: Reaction to recent regulatory guidance on multiple endpoints in clinical trials.
Wiens BL
J Biopharm Stat; 2018; 28(1):52-62. PubMed ID: 29065276
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous confidence intervals for an extended Koch-Röhmel design in three-arm non-inferiority trials.
Scharpenberg M; Brannath W
Stat Methods Med Res; 2023 Sep; 32(9):1784-1798. PubMed ID: 37503578
[TBL] [Abstract][Full Text] [Related]
19. Testing of non-inferiority and superiority for three-arm clinical studies with multiple experimental treatments.
Zhong J; Wen MJ; Kwong KS; Cheung SH
Stat Methods Med Res; 2018 Jun; 27(6):1751-1765. PubMed ID: 27647816
[TBL] [Abstract][Full Text] [Related]
20. Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT.
Scarborough M; Li HK; Rombach I; Zambellas R; Walker AS; McNally M; Atkins B; Kümin M; Lipsky BA; Hughes H; Bose D; Warren S; Mack D; Folb J; Moore E; Jenkins N; Hopkins S; Seaton RA; Hemsley C; Sandoe J; Aggarwal I; Ellis S; Sutherland R; Geue C; McMeekin N; Scarborough C; Paul J; Cooke G; Bostock J; Khatamzas E; Wong N; Brent A; Lomas J; Matthews P; Wangrangsimakul T; Gundle R; Rogers M; Taylor A; Thwaites GE; Bejon P
Health Technol Assess; 2019 Aug; 23(38):1-92. PubMed ID: 31373271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
